论文部分内容阅读
上海市医学会、上海市药学会与上海三维制药有限公司联合举办的新一代喹诺酮抗菌药“维沙欣”上市发布会于8月19日下午在上海富豪环球东亚酒店召开。上海市医学界和药学界共200多位人士参加会议。会议由上海市医学会副会长兼秘书长谈彬庸教授主持,上海三维制药有限公司总经理梅丽君女士对各界人士的光临表示诚挚的谢意。会上,上海华山医院著名感染病学家张梅芳教授作了关于左氧氟沙星目前临床应用的专题报告。 “维沙欣”的通用名是乳酸左氧氟沙星片,系同类产品氧氟沙星的光学活性左旋异构体。本品高效低毒,其抗菌活
Shanghai Medical Association, Shanghai Pharmaceutical Association and Shanghai 3D Pharmaceutical Co., Ltd. jointly organized a new generation of quinolone antibacterial drugs “Vaishaxin” listing conference was held on the afternoon of August 19 at Regal International East Asia Hotel in Shanghai. A total of more than 200 people from Shanghai Medical and Pharmacy participated in the conference. The meeting was chaired by Professor Tan Bin Yong, vice president and secretary general of Shanghai Medical Association. Ms. Mei Lijun, the general manager of 3D Pharmaceutical Co., Ltd., expressed her sincere gratitude to all walks of life. At the meeting, a famous infectious disease scientist at Shanghai Huashan Hospital, Professor Zhang Meifang made a lecture on the current clinical application of levofloxacin. The common name for “Vaishaxin” is levofloxacin lactate tablets, which is an optically active levorotatory of ofloxacin of similar type. This product is efficient and low toxicity, its antibacterial activity